Trial · NCT00867789
Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department
NCT00867789, Not applicable, Terminated, Children's Mercy Hospital Kansas City; results first posted 2021-01-26
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department. Trials, record NCT00867789. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00867789
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Antibiotics Versus Placebo in the Treatment of Abscesses in the Emergency Department
- NCT number
- NCT00867789
- Status
- Terminated
- Phases
- Not applicable
- Enrollment
- 140 participants, actual
- Lead sponsor
- Children's Mercy Hospital Kansas City
- Conditions
- Abscess
- Interventions
- Trimethoprim-sulfamethoxazole, Sugar pill
- First posted
- 2009-03-24
- Last updated
- 2021-01-26
- Results first posted
- 2021-01-26
Source ClinicalTrials.gov
Registered outcomes1
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Health Outcomes After Use With Trimethoprim-sulfamethaxazole | two years |
Source ClinicalTrials.gov
Outcomes1
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Health Outcomes After Use With Trimethoprim-sulfamethaxazole | two years | Percentage of outcomes assessed | NUMBER |
Source ClinicalTrials.gov
Results by group2
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Health Outcomes After Use With Trimethoprim-sulfamethaxazole | Trimethoprim-sulfamethaxazole | 0 | Percentage of outcomes assessed | ||
| Health Outcomes After Use With Trimethoprim-sulfamethaxazole | Sugar Pill | 0 | Percentage of outcomes assessed |
Source ClinicalTrials.gov
Participant flow6
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | Trimethoprim-sulfamethaxazole | 70 | |
| Overall Study | STARTED | Sugar Pill | 70 | |
| Overall Study | COMPLETED | Trimethoprim-sulfamethaxazole | 68 | |
| Overall Study | COMPLETED | Sugar Pill | 70 | |
| Overall Study | NOT COMPLETED | Trimethoprim-sulfamethaxazole | 2 | |
| Overall Study | NOT COMPLETED | Sugar Pill | 0 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals6
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | Trimethoprim-sulfamethaxazole | ||
| Total, all-cause mortality | Sugar Pill | ||
| Total, other adverse events | Trimethoprim-sulfamethaxazole | 0 | 70 |
| Total, other adverse events | Sugar Pill | 0 | 70 |
| Total, serious adverse events | Trimethoprim-sulfamethaxazole | 0 | 70 |
| Total, serious adverse events | Sugar Pill | 0 | 70 |
Source ClinicalTrials.gov
Papers18
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons1
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison |
|---|
| Trimethoprim-sulfamethaxazole vs Sugar Pill: serious adverse events |
Source Trial comparisons
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00867789
GET https://conductscience.org/api/trials/v1/NCT00867789/registered